Description

Imidazo[1,2-A]Pyridine-7-Carboxamide, n-2-Azabicyclo[2.2.1]Hept-6-Yl- (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its complex fused heterocyclic and bridged bicyclic structure. This compound is of significant value in medicinal chemistry for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly those targeting central nervous system (CNS) disorders and other specialized disease areas.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates, especially those with complex molecular architectures.
• Medicinal Chemistry Research: Used as a scaffold or building block in structure-activity relationship (SAR) studies and lead optimization programs within R&D laboratories.
• API Development: Integral to the process development and scale-up of new Active Pharmaceutical Ingredients (APIs) for preclinical and clinical trials.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for exploring new synthetic methodologies and bioactivity of imidazopyridine derivatives.

Basic Information

Product Name	Imidazo[1,2-A]Pyridine-7-Carboxamide, n-2-Azabicyclo[2.2.1]Hept-6-Yl- (9Ci)
CAS No.	588725-23-9
Molecular Formula	C14H16N4O
Molecular Weight	256.31 g/mol
Synonyms	N-(2-Azabicyclo[2.2.1]hept-6-yl)imidazo[1,2-a]pyridine-7-carboxamide; 7-Imidazo[1,2-a]pyridinecarboxamide, N-2-azabicyclo[2.2.1]hept-6-yl-; Imidazo[1,2-a]pyridine-7-carboxamide, N-(2-azabicyclo[2.2.1]hept-6-yl)-; 588725-23-9; Advanced Pharmaceutical Intermediate 588725-23-9
EINECS	Contact for details

Quality Control

This high-value intermediate is produced under strict quality management systems. Every batch undergoes comprehensive analytical characterization to ensure identity, purity, and consistency. Standard testing includes HPLC for assay and impurity profiling, alongside spectroscopic confirmation (NMR, IR, MS). A Certificate of Analysis (COA) detailing all test results is provided with each shipment. We support development and commercial projects requiring compliance with ICH guidelines and can tailor purity specifications to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The container should be kept in a well-ventilated area and protected from moisture. For long-term storage, consider under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.